News | Women's Health | August 01, 2017

The ACR-accredited breast imaging center installs Fujifilm's ASPIRE Cristalle, the digital FFDM system with DBT

The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow

Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast imaging center based in Monterey, Cali., has installed Fujifilm’s ASPIRE Cristalle FFDM system with Digital Breast Tomosynthesis (DBT). The innovative 3-D breast imaging technology has been in use at the center since April.

“We are pleased and excited that The Mammography Center has selected Fujifilm’s ASPIRE Cristalle with DBT. It is especially gratifying to know that women in the Monterey area have access to advanced technology such as breast tomosynthesis in their own community,” said Rob Fabrizio, director of strategic marketing, digital radiography and women’s health, Fujifilm Medical Systems U.S.A., Inc. “We look forward to continuing to support The Mammography Center of Monterey in their efforts to educate women and build awareness about the benefits of 3-D mammography with both clinicians and patients.”

In business for 28 years, The Mammography Center of Monterey was seeking to expand its offerings with the latest mammography technology. The facility decided to make an investment in the latest advanced technology versus staying with a traditional 2-D system. After evaluating competitive breast tomosynthesis units—and speaking with both a technologist and a radiologist familiar with the ASPIRE Cristalle—the facility opted for Fujifilm’s ASPIRE Cristalle.

“Radiologists at the center are impressed with the technology and their ability to clearly see details, especially in images of dense breast tissue,” said Mary Lou Catania, RN, founder and president, The Mammography Center of Monterey.

According to Catania, since the center began using ASPIRE Cristalle with DBT, recall rates have dropped and in fact, there have been no patients recalled due to dense breast images.

Catania also stated that the Fujifilm system is easy-to-use, comfortable for patients, and affordable. She credits the company with a smooth installation and excellent training, saying technologists quickly got up to speed on the ASPIRE Cristalle and were able to rapidly get back on track performing a backlog of patient exams.

The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow to optimize patient dose while maximizing image quality.

For more information: www.fujimed.com

 


Related Content

News | MRI Breast

June 12, 2024 — Royal Philips recently announced the 1,111th installation of its revolutionary BlueSeal 1.5T magnet ...

Time June 12, 2024
arrow
News | Breast Imaging

June 7, 2024 — Scholars and studies funded by Susan G. Komen(R), the world’s leading breast cancer organization ...

Time June 07, 2024
arrow
News | Breast Density

June 6, 2024 — Subsequent rounds of abbreviated breast MRI (AB-MR) screening in patients with dense breasts had lower ...

Time June 06, 2024
arrow
News | Breast Imaging

June 4, 2024 — Using artificial intelligence (AI), breast radiologists in Denmark have improved breast cancer screening ...

Time June 04, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

As we flip the page to a new month on our calendars, here is a look at the Top 10 pieces of content viewers were reading ...

Time June 04, 2024
arrow
News | Breast Imaging

May 28, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time May 28, 2024
arrow
News | FDA

May 22, 2024 — The U.S. Food and Drug Administration (FDA) has issued a recall of the Hologic Inc. BioZorb marker due to ...

Time May 22, 2024
arrow
News | Artificial Intelligence

May 22, 2024 — Lunit, a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and ...

Time May 22, 2024
arrow
News | Radiology Business

May 6, 2024 — ScreenPoint Medical’s Board of Directors has announced the appointment of Peter Kroese as the new Chief ...

Time May 06, 2024
arrow
News | Mammography

May 6, 2024 — Enable Me, a VELA Medical company, cited major new research by Siemens Healthineers entitled, “The future ...

Time May 06, 2024
arrow
Subscribe Now